Literature DB >> 24820799

[Severe drug-induced skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis].

M Mockenhaupt1.   

Abstract

Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) are characterized by extensive blistering of the skin and mucosa; they are considered as one disease entity with varying severity. They are rare but potentially life-threatening and accompanied by high mortality. A clear clinical diagnosis is needed to direct specific therapy, but supportive therapy remains most important. In order to identify and withdraw the inducing drug, a very detailed and thorough medication history has to be obtained. Among the highly suspected (strongly associated) agents are allopurinol, antibacterial sulfonamides, non-steroidal anti-inflammatory drugs of the oxicam type, various anti-epileptics and nevaripine. Together they account for more than half of the cases of SJS/TEN. Although a drug is not always the cause, it is considered very like in approximately 75% of cases. Infections have also to be considered as etiologic factors.

Entities:  

Mesh:

Year:  2014        PMID: 24820799     DOI: 10.1007/s00105-013-2694-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

Authors:  B Rzany; M Mockenhaupt; S Baur; W Schröder; U Stocker; J Mueller; N Holländer; R Bruppacher; E Schöpf
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

2.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Jui-Yung Yang; Shih-Chi Su; Shien-Ping Huang; Chun-Yu Wei; See-Wen Chin; Chien-Chun Chiou; Sung-Chao Chu; Hsin-Chun Ho; Chih-Hsun Yang; Chi-Fang Lu; Jer-Yuarn Wu; You-Di Liao; Yuan-Tsong Chen
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

3.  Stevens-Johnson syndrome/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians regarding the risk?

Authors:  Cynthia Haddad; Alexis Sidoroff; Sylvia H Kardaun; Maja Mockenhaupt; Daniel Creamer; Ariane Dunant; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

4.  Epidemiology of staphylococcal scalded skin syndrome in Germany.

Authors:  Maja Mockenhaupt; Marco Idzko; Martine Grosber; Erwin Schöpf; Johannes Norgauer
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 5.  Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes.

Authors:  Manuel Florian Struck; Peter Hilbert; Maja Mockenhaupt; Beate Reichelt; Michael Steen
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

6.  Immune pathomechanism of drug hypersensitivity reactions.

Authors:  Werner J Pichler; Dean J Naisbitt; B Kevin Park
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

7.  Drug hypersensitivity: pharmacogenetics and clinical syndromes.

Authors:  Elizabeth J Phillips; Wen-Hung Chung; Maja Mockenhaupt; Jean-Claude Roujeau; Simon A Mallal
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

Review 8.  Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

Authors:  Pierre-Dominique Ghislain; Jean-Claude Roujeau
Journal:  Dermatol Online J       Date:  2002-06

9.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Authors:  Ariane Auquier-Dunant; Maja Mockenhaupt; Luigi Naldi; Osvaldo Correia; Werner Schröder; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2002-08

10.  Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.

Authors:  Sima Halevy; Pierre-Dominique Ghislain; Maja Mockenhaupt; Jean-Paul Fagot; Jan Nico Bouwes Bavinck; Alexis Sidoroff; Luigi Naldi; Ariane Dunant; Cecile Viboud; Jean-Claude Roujeau
Journal:  J Am Acad Dermatol       Date:  2007-10-24       Impact factor: 11.527

View more
  2 in total

Review 1.  [Mucosal diseases from an allergological perspective].

Authors:  I Schwarz; D Bokanovic; W Aberer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

2.  [Unintended rechallenge : Generalized bullous fixed drug eruption in two elderly women].

Authors:  M Paulmann; M Mockenhaupt
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.